References
- Editorial. Asthma at night. Lancet 1983; 1: 220–222
- Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85(Suppl 1B)6–8
- Barnes P J. Nocturnal asthma: Mechanisms and treatment. Br Med J 1984; 288: 1397–1398
- Guidelines for management of asthma in adults. I. Chronic persistent asthma. Statement by the British Thoracic Society. Br Med J 1990; 301: 651–653
- Horn C R, Clark T JH, Cochrane G M. Inhaled therapy reduces morning dips in asthma. Lancet 1984; 1: 1143–1145
- Hendeles L, Weinberger M. Theophylline: A state of the art review. Pharmacotherapy 1983; 3: 2–44
- Welsh P W, Reed C E, Conrad E. Timing of once-a-day theophylline dose to match peak blood level with diurnal variation in severity of asthma. Am J Med 1986; 50: 1098–1102
- Martin R J, Cicutto L C, Ballard R D, Goldenheim P D, Chemiack R M. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139: 475–478
- Dahl R, Harving H, Säwedal L, Anehus S. Terbutaline sustained-release tablets in nocturnal asthma—A placebo-controlled comparison between a high and a low evening dose. Br J Dis Chest 1988; 82: 237–241
- Eriksson L, Jonson B, Eklundh G, Persson G. Nocturnal asthma: Effects of slow-release terbutaline on spirometry and arterial blood-gases. Eur Respir J 1988; 1: 302–305
- Fairfax A J, McNabb W R, Davies H J, Spiro S G. Slow-release oral salbutamol and aminophylline in nocturnal asthma: Relation of overnight changes in lung function and plasma drug levels. Thorax 1980; 35: 526–530
- Milroy R, Carter R, Carlyle D, Boyd G. Clinical and pharmacological study of a novel controlled release preparation of salbutamol. Br J Clin Pharmacol 1990; 29: 578–580
- Maesen F PV, Smeets J J. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease. Eur J Pharmacol 1986; 31: 431–436
- Pauwels R, Elinck W, Lamont H, Van der Straeten M, Ljungholm K. A comparison of the clinical and bronchodilating effects of plain and slow-release tablets of terbutaline at steady state. Br J Clin Pharmacol 1986; 21: 217–222
- Stewart I C, Rhind G B, Power J T, Frenley D C, Douglas N J. Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma. Thorax 1987; 42: 797–800
- Storms W W, Nathan R A, Bodman S F, et al. The effect of repeat action albuterol sulfate (Proventil Repetabs) in nocturnal symptoms of asthma. J Asthma 1992; 29: 209–216
- Higgenbottam T W, Khan Ali MA, Williams D O, Mikhail J R, Peake M D, Hughes J. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction. J Intern Med Res 1989; 17: 435–441
- Brander P E, Sovijärvi A RA, Salmi T, Hakulinen A, Poppius H. Nocturnal oxygen saturation and body movement in asthmatics treated with controlled-release preparations of theophylline or terbutaline. Eur J Clin Pharmacol 1990; 39: 117–121
- Heins M, Kurtin L, Oellerich M, Maes R, Sybrecht G W. Nocturnal asthma: Slow-release terbutaline versus slow-release theophylline therapy. Eur Respir J 1988; 1: 306–310
- Milledge J S, Morris J. A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma. J Intern Med Res 1979; 1: 106–110
- Pierson W E, La Force C F, Bell T D, MacCosbe P E, Sykes R S, Tinkelman D. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol 1990; 85: 618–626
- Hussey E K, Donn K H, Powell J R, Lahey A P, Pakes G E. Albuterol extended-release products: Effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil repetabs in healthy male volunteers. J Clin Pharmacol 1991; 31: 561–564
- MacDonald J B. Nocturnal asthma, what happens to the airways at night?. Br Med J 1992; 304: 998–989
- Fitzpatrick M F, Mackay T, Driver H, Douglas N J. Salmeterol in nocturnal asthma: A double blind, placebo controlled trial of a long acting inhaled β2 agonist. Br Med J 1990; 301: 1365–1368
- Schnabel D, Sybrecht G, Hemmerling T. Protective efficacy of formoterol compared with theophylline in patients with nocturnal bronchial asthma. Formoterol in Asthma, R J Davies. Hogrefe and Huber, Toronto 1988; 23–28